JBCHEPHARMNSEJB Chemicals & Pharmaceuticals Limited· PharmaceuticalsMediumNeutral
Announced Tue, 24 Mar · 19:21 IST

JB Chemicals & Pharmaceuticals Limited has informed regarding Disclosure under Regulation 30 in relation to Scheme of Amalgamation

Nclt Scheme FiledListed Co AcquisitionStrategic Transactions View source PDF

JBCHEPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.3%1-day move
₹2070.00
prior close
₹2092.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.2-0.3-0.2-0.3-0.2-3.4-5.4-5.7-6.0-3.7-1.0+7.5+7.4
Up moveDown movePending
AI summary

JB Chemicals & Pharmaceuticals has informed that the NCLT Ahmedabad Bench has uploaded its order on March 23, 2026, regarding the first motion application for the proposed amalgamation of JB Chemicals (Transferor Company) with Torrent Pharmaceuticals (Transferee Company). This is a continuation of the company's earlier intimation dated June 29, 2025. The scheme of amalgamation between the two pharma companies is progressing through the NCLT approval process. The next steps would involve shareholder and creditor approvals before the final order.

Likely market impact

Positive for shareholders as the merger moves closer to completion, potentially unlocking value through Torrent's larger platform. However, share price may remain range-bound until final NCLT approval, swap ratio confirmation, and completion timelines are clearer.